ArticleiScience2026

Efficacy and safety of adding induction therapy for unresectable NSCLC receiving cCRT and consolidation immunotherapy: A retrospective study.

Yuliang Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.